KLK3 and benign prostatic hyperplasia: According to these results, Llop et al.27 described using PhoSL lectin, a significant decrease of core fucosylation in serum PSA in a cohort of high-risk PCa patients vs. BPH patients with 90% sensitivity and 95% specificity, with an AUC of 0.94.